Notably, anakinra seems to show effectiveness in treating nephrotic syndrome in individuals with AA amyloidosis and autoinflammatory disease linked to CIAS1/NALP3/cryopyrin gene mutations [34]. The gene discussed is NLRP3; the disease is nephrotic syndrome.